 ?您的位置：對(duì)照品 > 標(biāo)準(zhǔn)物質(zhì) > 計(jì)量院標(biāo)準(zhǔn)物質(zhì) > |
|
|
|
| 產(chǎn)品基本信息 |
|
| 產(chǎn)品編號(hào)：L474700 |
| 產(chǎn)品名稱(chēng)：Lumiracoxib |
| 產(chǎn)品CAS：220991-20-8 |
| 規(guī)格含量：10mg |
| 產(chǎn)品價(jià)格：面議 |
| 聯(lián)系我們: |
 |
|
 |
|
|
| 產(chǎn)品詳細(xì)介紹 |
| 標(biāo)準(zhǔn)品編號(hào): |
L474700 |
| 名稱(chēng): |
Lumiracoxib |
| 別名: |
2-[(2-Chloro-6-fluorophenyl)amino]-5-methylbenzeneacetic Acid; 2-[2-(2-Chloro-6-fluorophenylamino)-5-methylphenyl]acetic Acid; CGS 35189; COX 189; Prexige; |
| CAS號(hào): |
220991-20-8 |
| 分子式: |
C??H??ClFNO? |
| 外觀: |
淡黃色固體 |
| 熔點(diǎn): |
136-150?C |
| 分子量: |
293.72 |
| 儲(chǔ)存: |
-20°C Freezer |
| 溶解度: |
DMSO (Slightly), Methanol (Slightly) |
| 種類(lèi): |
Standards; Pharmaceutical/API Drug Impurities/Metabolites; |
| 應(yīng)用: |
Lumiracoxib is a selective cyclooxygenase-2-(COX-2) inhibitor and an anti-inflammatory agent (1,2,3,4). |
| 參考文獻(xiàn) |
|
|
|
|
|
|
|
|
